Weighing options: empiric antibiotic use and stewardship opportunities in critically ill patients with community-acquired pneumonia

In this retrospective study, critically ill patients with community-acquired pneumonia frequently received empiric anti-methicillin-resistant Staphylococcus aureus (MRSA) and antipseudomonal antibiotics despite having few or no guidelines-endorsed risk factors. De-escalation of anti-MRSA therapy was...

Full description

Saved in:
Bibliographic Details
Main Authors: Nalea Trujillo, Calvin Diep, David Ha, Ariadna Garcia, Marisa Holubar
Format: Article
Language:English
Published: Cambridge University Press 2025-01-01
Series:Antimicrobial Stewardship & Healthcare Epidemiology
Online Access:https://www.cambridge.org/core/product/identifier/S2732494X2510082X/type/journal_article
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In this retrospective study, critically ill patients with community-acquired pneumonia frequently received empiric anti-methicillin-resistant Staphylococcus aureus (MRSA) and antipseudomonal antibiotics despite having few or no guidelines-endorsed risk factors. De-escalation of anti-MRSA therapy was quicker, likely aided by MRSA polymerase chain reaction assays.
ISSN:2732-494X